Royce & Associates’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Hold	94,017	–	–	0.16%	202
2025 Q4	$17.2M	Buy	94,017 +37,981	+68%	+$5.3M	0.17%	180
2025 Q3	$6.81M	Buy	56,036 +30,279	+118%	+$3.41M	0.07%	402
2025 Q2	$2.69M	Sell	25,757 -4,500	-15%	-$476K	0.03%	559
2025 Q1	$3.53M	Sell	30,257 -6,743	-18%	-$768K	0.04%	498
2024 Q4	$3.13M	Buy	37,000 +14,500	+64%	+$1.33M	0.03%	559
2024 Q3	$2.02M	Buy	22,500 +9,500	+73%	+$829K	0.02%	620
2024 Q2	$1.05M	Hold	13,000	–	–	0.01%	715
2024 Q1	$1.04M	Buy	+13,000	New	+$1.09M	0.01%	721
2021 Q3	–	Sell	-20,300	Closed	-$1.37M	–	985
2021 Q2	$1.37M	Sell	20,300 -5,400	-21%	-$324K	0.01%	813
2021 Q1	$1.46M	Hold	25,700	–	–	0.01%	803
2020 Q4	$2.09M	Hold	25,700	–	–	0.02%	715
2020 Q3	$1.83M	Hold	25,700	–	–	0.02%	694
2020 Q2	$2.12M	Sell	25,700 -14,400	-36%	-$1.11M	0.02%	656
2020 Q1	$2.36M	Sell	40,100 -20,000	-33%	-$1.63M	0.03%	559
2019 Q4	$6.21M	Sell	60,100 -44,600	-43%	-$1.8M	0.06%	436
2019 Q3	$2.12M	Sell	104,700 -10,000	-9%	-$257K	0.02%	696
2019 Q2	$2.95M	Sell	114,700 -67,700	-37%	-$1.36M	0.03%	624
2019 Q1	$2.6M	Sell	182,400 -150,000	-45%	-$1.39M	0.02%	665
2018 Q4	$937K	Hold	332,400	–	–	0.01%	871
2018 Q3	$1.15M	Sell	332,400 -556,000	-63%	-$1.65M	0.01%	899
2018 Q2	$2.84M	Sell	888,400 -67,600	-7%	-$209K	0.02%	751
2018 Q1	$2.34M	Buy	956,000 +75,000	+9%	+$225K	0.02%	807
2017 Q4	$4.93M	Hold	881,000	–	–	0.03%	590
2017 Q3	$4.89M	Hold	881,000	–	–	0.03%	576
2017 Q2	$4.85M	Hold	881,000	–	–	0.03%	597
2017 Q1	$3.44M	Buy	+881,000	New	+$4.21M	0.02%	705